SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Mohilner who wrote (249)11/8/2001 12:26:39 AM
From: scaram(o)uche  Read Replies (1) of 1022
 
>> While it's not a part of that article, it should be recognized that the majority of the MAB's that MEDX and others can create by themselves may have little or no curative benefits. <<

Why do you say that? A number of toxin conjugates have failed in the clinic (including two ricin conjugates from IMGN), while anti-CD20, anti-Her2/neu, anti-RSV, etc. have proven to be quite effective.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News